Integrating Pharmacometrics and Machine Learning for Enhanced Clinical Trial Outcomes

A novel computational framework that integrates the mechanistic rigor of Pharmacometrics (PMx) with the predictive power of Multimodal Machine Learning (MML) is conceptually formulated and discussed. The framework is designed to address critical developmental bottlenecks in the drug development sector, which is already witnessing a paradigm shift driven by the rise of Antibody-Drug Conjugates (ADCs)—a class that, according to recent pipeline analyses, accounts for an expanding share of innovative oncology trials. Unfortunately, despite the therapeutic promise of ADCs and other targeted modalities, the industry faces a productivity paradox, characterized by high attrition rates in transitional clinical phases and a median development timeline of seven years. By leveraging transfer learning strategies, we delineate how the synergistic adoption of PMx and MML can conceptually optimize dose selection, inform metastatic risk assessment through genomic-imaging integration, and ultimately accelerate the transition from bench to bedside. This is conceptualized through the definition of methodologies capable of transforming noisy early-phase clinical data into actionable insights, thus bridging the gap between Physiologically Based Pharmacokinetic (PBPK) modeling and deep learning-driven outcomes. Without advancing premature empirical claims, we establish a structured methodological roadmap for a scalable, AI-enhanced clinical trial infrastructure, positioning hybrid modeling as a viable architectural paradigm for the next generation of precision oncology.

Authors

Institutions

Publication Details

Journal
WSEAS TRANSACTIONS ON SYSTEMS AND CONTROL
Published
2026-11-16
DOI
https://doi.org/10.37394/23203.2026.21.46
Primary Topic
Statistical Methods in Clinical Trials
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrating Pharmacometrics and Machine Learning for Enhanced Clinical Trial Outcomes

Maria Cacciapuoti, Alessandro Minella, Mauro D’arco
3 links
WSEAS TRANSACTIONS ON SYSTEMS AND CONTROL
Statistical Methods in Clinical Trials
article

Integrating Pharmacometrics and Machine Learning for Enhanced Clinical Trial Outcomes

Maria Cacciapuoti, Alessandro Minella, Mauro D’arco
article en

Abstract

A novel computational framework that integrates the mechanistic rigor of Pharmacometrics (PMx) with the predictive power of Multimodal Machine Learning (MML) is conceptually formulated and discussed. The framework is designed to address critical developmental bottlenecks in the drug development sector, which is already witnessing a paradigm shift driven by the rise of Antibody-Drug Conjugates (ADCs)—a class that, according to recent pipeline analyses, accounts for an expanding share of innovative oncology trials. Unfortunately, despite the therapeutic promise of ADCs and other targeted modalities, the industry faces a productivity paradox, characterized by high attrition rates in transitional clinical phases and a median development timeline of seven years. By leveraging transfer learning strategies, we delineate how the synergistic adoption of PMx and MML can conceptually optimize dose selection, inform metastatic risk assessment through genomic-imaging integration, and ultimately accelerate the transition from bench to bedside. This is conceptualized through the definition of methodologies capable of transforming noisy early-phase clinical data into actionable insights, thus bridging the gap between Physiologically Based Pharmacokinetic (PBPK) modeling and deep learning-driven outcomes. Without advancing premature empirical claims, we establish a structured methodological roadmap for a scalable, AI-enhanced clinical trial infrastructure, positioning hybrid modeling as a viable architectural paradigm for the next generation of precision oncology.

WSEAS TRANSACTIONS ON SYSTEMS AND CONTROLVol. 21
University of Naples Federico II (IT)
Good health and well-being
Statistical Methods in Clinical Trials
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon